DOSSIER · 13F-HR · Q3 2026

BIOS Capital Management, LP

$34M in tracked AUM across 9 positions as of Q3 2026.

BC
CIK 0001813845 · last filed Sep 30, 2026
Total AUM
$34M
as of Q3 2026
Holdings
9
+0 QoQ
positions
Whale Score
63
63
tracked
Activity
1
+0 new, −0 sold
changes this Q
AI Analysis · Q3 2026

BIOS Capital Management, LP filed its latest 13F-HR for Q3 2026. 1 position changes this quarter — 0 new, 0 exited, 0 added, 1 trimmed.

Quarter at a glance — Q3 2026

1 material changes this filing.

TRIM
LTRNLANTERN PHARMA INC
-14K sh
$-802K
0.7%

Top 10 holdings

By portfolio weight as of Q3 2026. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
IRD
OPUS GENETICS INC
$18M3.7M52.2%
02
ACTU
ACTUATE THERAPEUTICS INC
$8M10.0M22.9%
03
CGTX
COGNITION THERAPEUTICS INC
$6M6.0M16.9%
04
RNTX
REIN THERAPEUTICS INC
$2M3.0M7.0%
05
LTRN
LANTERN PHARMA INC
$238K236K0.7%
06
INAB
IN8BIO INC
$108K81K0.3%

Filing history

2026Q3Sep 30
$34M▼ 18.0%
9 positionsView →
2026Q2Jun 30
$42M▼ 21.2%
9 positionsView →
2026Q1Mar 31
$53M▼ 36.0%
10 positionsView →
2025Q4Dec 31
$83M▲ 292.4%
9 positionsView →
2025Q3Sep 30
$21M▼ 71.0%
6 positionsLocked
2025Q2Jun 30
$73M▲ 573.9%
9 positionsLocked
2025Q1Mar 31
$11M▼ 88.8%
6 positionsLocked
2024Q4Dec 31
$96M—
9 positionsLocked